Stocks TradingCharts.com

stocks prices, charts & quotes

Free Stock Prices, Charts & Stock Price Quotes

Search
Symbol Search Browse Symbols My Charts Menu
QUICK QUOTE
QUICK CHART
F.A.Questions Suggestion Box Advertising Info Commodity Charts Forex Markets

Stocks & Financial News

Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts

OneMedNet Stock Soars 90% Following Real-World Data Platform Launch

Feb 27, 2026 (PRISM News via COMTEX) --

Shares of OneMedNet Corporation (NASDAQ:ONMD) surged 90% in Friday trading following the announcement of its next commercial launch phase. The company is advancing its Real-World Data (RWD) Platform, which is powered by Palantir Foundry.

Following successful demonstrations at major tradeshows on November 10, 2025, OneMedNet is now converting customer evaluations into commercial subscriptions. The company reports it is securing multi-year subscription deals, which represent millions in incremental recurring revenue. This growing adoption spans the life sciences and AI health sectors.

The platform offers access to multimodal datasets from over 2,130 healthcare sites. Customer feedback gathered since Fall 2025 has highlighted the platform’s analytical depth across integrated clinical and longitudinal datasets. Users also noted accelerated cohort feasibility and faster onboarding for data partners.

OneMedNet’s iRWD network provides continuously connected datasets with over two decades of historical depth and access extending three years forward. The platform merges AI-driven search capabilities with real-time data feeds to enhance evidence generation.

“Customer feedback has reinforced the platform's performance, speed, and depth of discovery,” stated Aaron Green, CEO & President of OneMedNet. “We believe this traction validates our strategy of combining conversational AI-driven search with scalable, prospective data feeds, strengthening customer confidence as we expand subscriptions and deliver fast, intuitive value for Real-World evidence generation.”

OneMedNet specializes in providing regulatory-grade, AI-ready Real-World Data to life sciences and healthcare organizations. This commercial launch significantly advances the company’s recurring revenue model through its focus on multi-year subscription contracts.

For more information on OneMedNet please visit www.onemednet.com .

The post OneMedNet Stock Soars 90% Following Real-World Data Platform Launch appeared first on PRISM MarketView.

comtex tracking

COMTEX_474345168/2927/2026-02-27T13:00:42

Do not sell my personal information

Copyright © 2026. All market data is provided by Barchart Solutions. Information is provided "as is" and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.